Anh Nguyen MD, PhD , Abbas Rana MD , Alexis Shafii MD , Gabriel Loor MD , Andrew Civitello MD , Jose Euberto Mendez Reyes MD, MPH , O. Howard Frazier MD , Todd Rosengart MD , Kenneth Liao MD, PhD
{"title":"循环死亡与脑死亡供者心脏移植受者的中期生存差异","authors":"Anh Nguyen MD, PhD , Abbas Rana MD , Alexis Shafii MD , Gabriel Loor MD , Andrew Civitello MD , Jose Euberto Mendez Reyes MD, MPH , O. Howard Frazier MD , Todd Rosengart MD , Kenneth Liao MD, PhD","doi":"10.1016/j.jhlto.2025.100342","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study builds upon previous analyses by examining heart transplant survival from donation after circulatory death (DCD) vs donation after brain death (DBD) using the United Network for Organ Sharing (UNOS) database, with follow-up extended to 3 years post-transplant.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 1,453 DCD and 16,561 DBD adult heart transplants from January 2019 to June 2024 using the UNOS database. Propensity scores were generated based on clinically relevant covariates, and 1-to-1 propensity-score matching was performed. Survival analysis was conducted using Cox proportional hazards regression and Kaplan-Meier curves, with the log-rank test comparing overall survival and the Wald test examining yearly survival rates between DCD and DBD groups.</div></div><div><h3>Results</h3><div>Mortality was not significantly different between DCD and DBD total cohorts (hazard ratio [HR] = 1.1, 95% confidence interval [CI] 0.9-1.3, <em>p</em> = 0.493). After propensity-score matching, balanced cohorts of 1,423 DCD and 1,423 DBD transplants were created with standardized mean difference among covariates well below 6%. In the matched cohort, DCD transplant mortality was 1.2 times higher than that of DBD transplants (HR 1.2, 95% CI 0.9-1.5). Kaplan-Meier curves revealed nonsignificantly lower overall survival for DCD recipients (log-rank <em>p</em> = 0.096). Survival rates were comparable in year 1: 91.6% vs 91.5%, <em>p</em> = 0.96, but significant differences emerged in subsequent years: 84.7% vs 89.4%, <em>p</em> = 0.007 in year 2; 80.3% vs 85.6%, <em>p</em> = 0.025 in year 3.</div></div><div><h3>Conclusions</h3><div>Intermediate-term survival following DCD heart transplantation may be lower compared to DBD transplantation. Further investigation is warranted to identify the underlying factors contributing to this potential disparity.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"9 ","pages":"Article 100342"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential intermediate-term survival differences among heart transplant recipients from circulatory death vs brain death donors\",\"authors\":\"Anh Nguyen MD, PhD , Abbas Rana MD , Alexis Shafii MD , Gabriel Loor MD , Andrew Civitello MD , Jose Euberto Mendez Reyes MD, MPH , O. Howard Frazier MD , Todd Rosengart MD , Kenneth Liao MD, PhD\",\"doi\":\"10.1016/j.jhlto.2025.100342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>This study builds upon previous analyses by examining heart transplant survival from donation after circulatory death (DCD) vs donation after brain death (DBD) using the United Network for Organ Sharing (UNOS) database, with follow-up extended to 3 years post-transplant.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 1,453 DCD and 16,561 DBD adult heart transplants from January 2019 to June 2024 using the UNOS database. Propensity scores were generated based on clinically relevant covariates, and 1-to-1 propensity-score matching was performed. Survival analysis was conducted using Cox proportional hazards regression and Kaplan-Meier curves, with the log-rank test comparing overall survival and the Wald test examining yearly survival rates between DCD and DBD groups.</div></div><div><h3>Results</h3><div>Mortality was not significantly different between DCD and DBD total cohorts (hazard ratio [HR] = 1.1, 95% confidence interval [CI] 0.9-1.3, <em>p</em> = 0.493). After propensity-score matching, balanced cohorts of 1,423 DCD and 1,423 DBD transplants were created with standardized mean difference among covariates well below 6%. In the matched cohort, DCD transplant mortality was 1.2 times higher than that of DBD transplants (HR 1.2, 95% CI 0.9-1.5). Kaplan-Meier curves revealed nonsignificantly lower overall survival for DCD recipients (log-rank <em>p</em> = 0.096). Survival rates were comparable in year 1: 91.6% vs 91.5%, <em>p</em> = 0.96, but significant differences emerged in subsequent years: 84.7% vs 89.4%, <em>p</em> = 0.007 in year 2; 80.3% vs 85.6%, <em>p</em> = 0.025 in year 3.</div></div><div><h3>Conclusions</h3><div>Intermediate-term survival following DCD heart transplantation may be lower compared to DBD transplantation. Further investigation is warranted to identify the underlying factors contributing to this potential disparity.</div></div>\",\"PeriodicalId\":100741,\"journal\":{\"name\":\"JHLT Open\",\"volume\":\"9 \",\"pages\":\"Article 100342\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHLT Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950133425001375\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133425001375","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本研究建立在先前分析的基础上,通过使用联合器官共享网络(UNOS)数据库检查循环死亡(DCD)和脑死亡(DBD)后捐赠的心脏移植存活率,随访时间延长至移植后3年。方法利用UNOS数据库,对2019年1月至2024年6月期间1453例DCD和16561例DBD成人心脏移植进行回顾性队列研究。根据临床相关协变量生成倾向评分,并进行1对1倾向评分匹配。采用Cox比例风险回归和Kaplan-Meier曲线进行生存分析,log-rank检验比较DCD组和DBD组的总生存率,Wald检验检查DCD组和DBD组的年生存率。结果DCD组与DBD组死亡率差异无统计学意义(风险比[HR] = 1.1, 95%可信区间[CI] 0.9 ~ 1.3, p = 0.493)。在倾向评分匹配后,创建了1423例DCD和1423例DBD移植的平衡队列,协变量之间的标准化平均差异远低于6%。在匹配的队列中,DCD移植死亡率是DBD移植死亡率的1.2倍(HR 1.2, 95% CI 0.9-1.5)。Kaplan-Meier曲线显示,DCD患者的总生存率无显著降低(log-rank p = 0.096)。第1年生存率比较:91.6% vs 91.5%, p = 0.96,但随后几年出现显著差异:第2年84.7% vs 89.4%, p = 0.007;80.3% vs 85.6%,第三年p = 0.025。结论DCD心脏移植的中期生存率较DBD低。有必要进行进一步调查,以确定造成这种潜在差距的潜在因素。
Potential intermediate-term survival differences among heart transplant recipients from circulatory death vs brain death donors
Background
This study builds upon previous analyses by examining heart transplant survival from donation after circulatory death (DCD) vs donation after brain death (DBD) using the United Network for Organ Sharing (UNOS) database, with follow-up extended to 3 years post-transplant.
Methods
We conducted a retrospective cohort study of 1,453 DCD and 16,561 DBD adult heart transplants from January 2019 to June 2024 using the UNOS database. Propensity scores were generated based on clinically relevant covariates, and 1-to-1 propensity-score matching was performed. Survival analysis was conducted using Cox proportional hazards regression and Kaplan-Meier curves, with the log-rank test comparing overall survival and the Wald test examining yearly survival rates between DCD and DBD groups.
Results
Mortality was not significantly different between DCD and DBD total cohorts (hazard ratio [HR] = 1.1, 95% confidence interval [CI] 0.9-1.3, p = 0.493). After propensity-score matching, balanced cohorts of 1,423 DCD and 1,423 DBD transplants were created with standardized mean difference among covariates well below 6%. In the matched cohort, DCD transplant mortality was 1.2 times higher than that of DBD transplants (HR 1.2, 95% CI 0.9-1.5). Kaplan-Meier curves revealed nonsignificantly lower overall survival for DCD recipients (log-rank p = 0.096). Survival rates were comparable in year 1: 91.6% vs 91.5%, p = 0.96, but significant differences emerged in subsequent years: 84.7% vs 89.4%, p = 0.007 in year 2; 80.3% vs 85.6%, p = 0.025 in year 3.
Conclusions
Intermediate-term survival following DCD heart transplantation may be lower compared to DBD transplantation. Further investigation is warranted to identify the underlying factors contributing to this potential disparity.